Phone: (212) 746-5788
Fax: (212) 746-0975
April 5, 2010 5:06 am
Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2009 ... - MarketWatch (press rele
Google News - bladder cancer
Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2009 ... MarketWatch (press release) These are Belinostat for PTCL and apaziquone for bladder cancer. In 2009 we completed enrollment of over 1600 patients in clinical trials with apaziquone. ... |
|